Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 1 of 1
Full-Text Articles in Medicine and Health Sciences
Comparison Of Response To 2-Years' Growth Hormone Treatment In Children With Isolated Growth Hormone Deficiency, Born Small For Gestational Age, Idiopathic Short Stature, Or Multiple Pituitary Hormone Deficiency: Combined Results From Two Large Observational Studies., Peter A Lee, Lars Sävendahl, Isabelle Oliver, Maithé Tauber, Oliver Blankenstein, Judith Ross, Marta Snajderova, Viatcheslav Rakov, Birgitte Tønnes Pedersen, Henrik Thybo Christesen
Comparison Of Response To 2-Years' Growth Hormone Treatment In Children With Isolated Growth Hormone Deficiency, Born Small For Gestational Age, Idiopathic Short Stature, Or Multiple Pituitary Hormone Deficiency: Combined Results From Two Large Observational Studies., Peter A Lee, Lars Sävendahl, Isabelle Oliver, Maithé Tauber, Oliver Blankenstein, Judith Ross, Marta Snajderova, Viatcheslav Rakov, Birgitte Tønnes Pedersen, Henrik Thybo Christesen
Department of Pediatrics Faculty Papers
BACKGROUND: Few studies have compared the response to growth hormone (GH) treatment between indications such as isolated growth hormone deficiency (IGHD), born small for gestational age (SGA), idiopathic short stature (ISS), and multiple pituitary hormone deficiency (MPHD). The aim of this analysis of data, collected from two large ongoing observational outcome studies, was to evaluate growth and insulin-like growth factor-I (IGF-I) response data for children of short stature with IGHD, MPHD, SGA, or ISS following two years of treatment with the recombinant GH product Norditropin® (Novo Nordisk A/S, Bagsværd, Denmark).
METHODS: Analysis of auxologic data from two ongoing prospective observational …